A phase II trial of regorafenib for advanced urothelial cancer (aUC) following prior chemotherapy

被引：1
|
作者：
Naik, Gurudatta
Vaishampayan, Ulka N.
Nabell, Lisle
De Shazo, Mollie R.
Nandagopal, Lakshminarayanan
Grivas, Petros
Morgan, Charity
Hardwick, Pamela
Sonpavde, Guru
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
498
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II trial of tamoxifen for progressive advanced urothelial carcinoma following prior chemotherapy
    Lerner, Seth P.
    Sternberg, Cora N.
    Younes, Mamoun
    Calabro, Fabio
    Cerbone, Linda
    Chandrashekar, A.
    Mitchell, Carmen
    Shen, Steven S.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] TENIPOSIDE IN ADVANCED BREAST-CANCER - A PHASE-II TRIAL IN PATIENTS WITH NO PRIOR CHEMOTHERAPY
    NIELSEN, D
    BOAS, J
    ENGELHOLM, SA
    HANSEN, OP
    DOMBERNOWSKY, P
    ANNALS OF ONCOLOGY, 1992, 3 (05) : 377 - 378
  • [3] Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial
    Pectasides, D
    Glotsos, J
    Bountouroglou, N
    Kouloubinis, A
    Mitakidis, N
    Karvounis, N
    Ziras, N
    Athanassiou, A
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 243 - 250
  • [4] RANDOMIZED PHASE-II TRIAL OF CARBOPLATIN AND IPROPLATIN IN ADVANCED UROTHELIAL CANCER
    DEWIT, R
    TESSELAAR, M
    KOK, TC
    SEYNAEVE, C
    RODENBURG, CJ
    VERWEIJ, J
    HELLE, PA
    STOTER, G
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (11) : 1383 - 1385
  • [5] Pembrolizumab ± chemotherapy versus chemotherapy in advanced urothelial cancer: Phase 3 KEYNOTE-361 trial
    Powles, T.
    Gschwend, J. E.
    Loriot, Y.
    Bellmunt, J.
    Geczi, L.
    Vulsteke, C.
    Abdelsalam, M.
    Gafanov, R.
    Bae, W. K.
    Revesz, J.
    Yamamoto, Y.
    Anido, U.
    Su, W-P.
    Fleming, M.
    Markus, M.
    Feng, D.
    Poehlein, C.
    Alva, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Regorafenib in Antiangiogenic-Naive, Chemotherapy-Refractory Advanced Colorectal Cancer: A Phase IIb Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (03) : 16 - 16
  • [7] Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer
    Vaughn, DJ
    Broome, CM
    Hussain, M
    Gutheil, JC
    Markowitz, AB
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 937 - 940
  • [8] A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)
    Grivas, P.
    Sridhar, S.
    Perez Valderrama, B.
    Castellano Gauna, D. E.
    Loriot, Y.
    Doger de Speville, B.
    Pouessel, D.
    van der Heijden, M. S.
    Galsky, M. D.
    Gulati, S.
    Ravaud, A.
    Fontana, E.
    Spira, A. I.
    Gartrell, B. A.
    Mortazavi, A.
    Isambert, N.
    Baxter, D.
    Powles, T. B.
    Khaled, A. H.
    Morales Barrera, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S1209 - S1210
  • [9] Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
    Pavlakis, Nick
    Sjoquist, Katrin M.
    Martin, Andrew J.
    Tsobanis, Eric
    Yip, Sonia
    Kang, Yoon-Koo
    Bang, Yung-Jue
    Alcindor, Thierry
    O'Callaghan, Christopher J.
    Burnell, Margot J.
    Tebbutt, Niall C.
    Rha, Sun Young
    Lee, Jeeyun
    Cho, Jae-Yong
    Lipton, Lara R.
    Wong, Mark
    Strickland, Andrew
    Kim, Jin Won
    Zalcberg, John R.
    Simes, John
    Goldstein, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2728 - +
  • [10] Regorafenib in antiangiogenic-naive, chemotherapy-refractory advanced colorectal cancer: A phase IIb trial.
    Riechelmann, Rachel Pimenta
    Leite, Luiz Antonio Senna
    Glasberg, Joao
    Bariani, Giovanni Mendonca
    Rivelli, Thomas Giollo
    Nebuloni, Daniela R.
    Puty, Fabiola
    Kappeler, Christian
    Pereira, Kaline M. C.
    Queiroz, Marcelo A.
    Hoff, Paulo Marcelo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345